On May 29, the Office of Management and Budget (OMB) published a proposed rule that would give political appointees the authority to block federally funded research on ideological grounds, prohibit entire categories of health services inquiry, defund the professional infrastructure that trains the next generation of researchers, and restrict how publicly funded science reaches the public it is meant to serve. The comment period closes July 13.
The rule has been framed as an accountability and burden-reduction measure. It is not. This is a science policy rule that reaches every stage of the research enterprise: what gets funded, what methods are permissible, whom researchers can work with, and how findings get disseminated. It should be recognized and debated as one. AcademyHealth has published a statement on the proposed rule here, and we are submitting formal comments before the July 13 deadline. We are writing here to explain why.
This Moment Is Different
In March 2025, AcademyHealth described a research enterprise under acute strain: funding freezes, indirect cost caps, data removals, workforce reductions. We urged the community to adapt, to document, to engage. That moment felt like a crisis. What OMB is now proposing is something categorically different.
The actions of early 2025 were exercises of executive discretion, subject to reversal by court order, congressional action, or a change in administration. This rule, if finalized, writes that discretion into federal regulation. It converts what was an emergency into a durable architecture. The fight over the comment period is not just about this rule. It is about whether the federal research enterprise emerges from this period with its structural integrity intact, or whether political control of science becomes the codified baseline from which future administrations must negotiate upward.
A Bargain and How This Rule Breaks It
The federal research enterprise was built on a basic bargain: public money, publicly accountable methods, publicly available findings. This rule breaks each leg of that bargain.
It makes the criteria for public money opaque and political. A new pre-issuance review process requires senior political appointees to confirm that every discretionary grant is consistent with the President's policy priorities before it is awarded. This is not an expansion of existing agency discretion. It is a codified, universal gate with no published standard, no appeals process, and no limiting principle. Peer review is explicitly reduced to an advisory function; the rule states plainly that it “does not replace agency discretion.” Under current practice, scientific merit is presumptively sufficient absent a specific reason to override it. Under this rule, political alignment is an affirmative threshold every award must clear.
It constrains the methods through which accountability is established. The rule embeds compliance standards defined by executive order rather than statute, including “Gold Standard Science,” “gender ideology,” and unlawful DEI activity. Because executive order definitions can be revised without rulemaking or public comment, grant conditions effectively track political priorities in real time. Recipients cannot plan compliance against a standard that moves without notice. There is no adjudication process before adverse action is taken. There is no meaningful right of appeal when an award is terminated for political rather than performance reasons. The government can define the rules, change the rules, and penalize you for violating them without a hearing.
It makes the dissemination of publicly funded findings administratively and financially untenable. Article processing charges and open access fees are broadly unallowable, a direct conflict with NIH’s own public access mandate, which simultaneously requires public dissemination of federally funded findings while this rule prohibits paying for it. Conference attendance requires advance agency approval baked into original award terms, meaning researchers cannot present findings at venues that become relevant after a grant is issued. Professional memberships require prior written approval; journal subscriptions are categorically unallowable. Together, these provisions restrict all three legs of the infrastructure through which federally funded science becomes useful: access to literature, participation in professional communities, and dissemination of findings.
It is worth noting that the rule’s primary evidentiary basis for these changes is not OIG findings or GAO audits documenting systematic misuse in peer-reviewed research programs. It is Heritage Foundation reports. The Heritage Foundation is not a methodology. When the justification for dismantling scientific independence is ideological rather than programmatic, the accountability framing does not hold.
The Disparate Impact Provision Deserves Particular Attention
Among the rule’s many troubling provisions, Section 200.218 stands apart. Federal awards may not be used to promote or support disparate-impact liability, including by funding disparate-impact studies or award activity driven by assumed disparate-impact risk. Demographic analysis is permitted only if federal funds are not used for it and the results are not applied to any activity under the award.
To be direct about what this means, a researcher cannot use a federal grant to study why Black women die in childbirth at three times the rate of white women, not if doing so implicates disparate-impact analysis. A health systems researcher cannot use federal funds to document whether patients with physical or cognitive disabilities receive fewer evidence-based interventions, if the analysis supports disparate-impact liability. A Medicaid policy researcher cannot apply demographic findings to federally funded work that might support disparate-impact accountability.
Disparate impact is not a political framework. It is a legal and analytical tool for identifying harm that operates through facially neutral policies and practices, the kind of harm that, by definition, does not announce itself. Health services research depends on it precisely because the most consequential inequities in US health care do not arise from explicit discrimination. They arise from coverage design, payment structure, care delivery patterns, and system architecture that produce unequal outcomes across populations. Prohibiting federally funded research from documenting and acting on those patterns does not make them disappear. It makes them invisible. And it does so using public money.
What Gets Damaged
The rule also has workforce implications that have received insufficient attention. Professional societies are not peripheral to the research enterprise. They are how researchers stay current, develop methodological skills, build peer networks, and enter the field. Restricting federal funds for memberships and conference participation does not just create administrative burden. It severs the connection between federally funded researchers and the communities of practice that make their work rigorous and relevant. The proposed controls over conference attendance, journal subscriptions, and memberships are administratively disproportionate to their cost and undermine the very mechanisms by which federally funded science becomes useful to anyone.
What gets damaged by this rule is not individual research projects. It is the infrastructure of evidence--the datasets, the research networks, the investigator pipelines, the dissemination channels that policymakers, practitioners, and patients depend on to make decisions that affect lives. That infrastructure took decades to build. It cannot be rebuilt quickly once it is gone.
What You Can Do
The comment period closes July 13, 2026. AcademyHealth has published a practical guide in the Situation Report that walks researchers and institutions through how to submit effective comments, including a template for reaching your institution's government affairs office. We urge members, partner organizations, and the broader research community to submit comments at regulations.gov (Docket OMB–2026–0034) and to make their voices heard through their institutions and professional associations. A flood of specific, substantive comments from researchers, institutions, and patients creates a record that is harder to ignore, harder to defend against in court, and harder to finalize without modification.
The federal government is proposing to substitute political control for scientific accountability and calling it reform. It should not go unanswered.